Lion Biotechnologies Inc

STU:2LB Germany

Market Cap

$35.28K

€34.37K EUR

Market Cap Rank

#42941 Global

#6814 in Germany

Share Price

€3.49

Change (1 day)

-15.27%

52-Week Range

€1.43 - €4.58

All Time High

€43.75

Lion Biotechnologies Inc - Asset Resilience Ratio

Latest as of June 2024: 19.07%

Lion Biotechnologies Inc (2LB) has an Asset Resilience Ratio of 19.07% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€183.86 Million

Cash + Short-term Investments

Total Assets

€964.32 Million

All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2023)

This chart shows how Lion Biotechnologies Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Lion Biotechnologies Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€183.86 Million	19.07%
Total Liquid Assets	€183.86 Million	19.07%

Asset Resilience Insights

Good Liquidity Position: Lion Biotechnologies Inc maintains a healthy 19.07% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.